How does NGS vs.

How does NGS vs. "Hot Spot" testing address the changes in cancer treatment, toward the use of molecularly targeted drugs prescribed to selected subsets of patients across multiple tumor types?

How does NGS vs. “Hot Spot” testing address the fundamental changes that systemic cancer treatment is undergoing, e.g. moving away from a paradigm in which histopathologically-defined disease is treated primarily with cytotoxic chemotherapy, toward the use of molecularly targeted drugs prescribed to selected subsets of patients across multiple tumor types?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Samuel Klempner, MD

Samuel Klempner, MD

Director of Precision Medicine
The Angeles Clinic and Research Institute
Cedars-Sinai Medical Center
Los Angeles, CA